Skip to main content

Adenosine Injection Shortage

Last Updated: August 27, 2024
Status: Current

Products Affected - Description
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 30 mL vial, 1 count, NDC 63323-0651-30
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 4 mL vial, 10 count, NDC 25021-0318-04
Reason for the Shortage
    • Akorn ceased operations in February 2023.
    • Pfizer discontinued adenosine in late-2022.
    • Eugia has adenosine injection available.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Sagent did not provide a reason for the shortage.
    • Teva is not currently marketing adenosine injection.
    • Viatris has adenosine injection available.
Available Products
    • Adenosine intravenous injection, Eugia US, 3 mg/mL, 20 mL vial, 1 count, NDC 55150-0192-01
    • Adenosine intravenous injection, Eugia US, 3 mg/mL, 30 mL vial, 1 count, NDC 55150-0193-01
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 20 mL vial, 1 count, NDC 63323-0651-20
    • Adenosine intravenous injection, Mylan (Viatris), 3 mg/mL, 20 mL vial, 1 count, NDC 67457-0856-20
    • Adenosine intravenous injection, Mylan (Viatris), 3 mg/mL, 30 mL vial, 1 count, NDC 67457-0857-30
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 2 mL syringe, 10 count, NDC 63323-0651-89
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 2 mL vial, 10 count, NDC 63323-0651-02
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 4 mL syringe, 10 count, NDC 63323-0651-90
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 4 mL vial, 10 count, NDC 63323-0651-04
    • Adenosine intravenous injection, Mylan (Viatris), 3 mg/mL, 2 mL vial, 10 count, NDC 67457-0855-02
    • Adenosine intravenous injection, Mylan (Viatris), 3 mg/mL, 4 mL vial, 10 count, NDC 67457-0854-04
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 2 mL prefilled syringe, 10 count, NDC 25021-0301-67
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 2 mL vial, 10 count, NDC 25021-0318-02
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 4 mL prefilled syringe, 10 count, NDC 25021-0301-68

Estimated Resupply Dates

    • Fresenius Kabi has short-dated 3 mg/mL 30 mL vials available with an expiration date of < 7 months.
    • Sagent has adenosine 3 mg/mL 4 mL vials on back order and the company estimates a release date of September 2024.

Updated

Updated August 27, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 3, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer